Serán BioScience Mentioned In Purdue News
Home
News
Serán BioScience Mentioned In Purdue News

Serán BioScience Mentioned In Purdue News

Serán is honored to continue partnership with Purdue University to make life-saving vaccines more accessible through development of new formulations and manufacturing processes for messenger RNA technology. Research teams from Purdue, Princeton, and Serán are looking at ways to aid supply chain concerns by developing delivery systems that do not have cold chain requirements and scaling these processes to large scale operations. Serán will provide process development and manufacturing support for this US-FDA funded three-year contract.

Download article

About Serán

Serán BioScience, LLC, is a science-driven drug development partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.

For more information, email us at hello@seranbio.com.

Contact

Brinette Holdren
Director of Marketing

Serán BioScience, LLC
63047 Layton Ave,
Bend, OR 97701 USA

Phone: (541)-237-8501
www.seranbio.com

Ready to get started?

Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product.

By clicking “Accept All Cookies”,  you agree to the storing of cookies on your device to enhance your browsing experience, understand how visitors interact with our website, analyze our traffic and personalize delivery of the content you are most interested in. View our Privacy Policy for more information.